Cargando…
GNAQ and BRAF mutations show differential activation of the mTOR pathway in human transformed cells
Somatic mutations in GNAQ gene were described as being the main oncogenic activation in uveal melanomas, whereas mutations in BRAF gene have been described as a key genetic alteration that contributes to skin melanoma development. We have previously reported differential activation of the MAPK and A...
Autores principales: | Pópulo, Helena, Tavares, Sandra, Faustino, Alexandra, Nunes, Joana B., Lopes, José Manuel, Soares, Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728761/ https://www.ncbi.nlm.nih.gov/pubmed/23904987 http://dx.doi.org/10.7717/peerj.104 |
Ejemplares similares
-
The mTOR Signalling Pathway in Human Cancer
por: Pópulo, Helena, et al.
Publicado: (2012) -
Combinatorial Therapies to Overcome BRAF/MEK Inhibitors Resistance in Melanoma Cells: An in vitro Study
por: Pópulo, Helena, et al.
Publicado: (2021) -
BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi
por: Francis, Jasmine H., et al.
Publicado: (2018) -
BRAF, GNAQ, and GNA11 mutations and copy number in pediatric low-grade glioma
por: Laviv, Yosef, et al.
Publicado: (2012) -
Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)